
RFK Jr.'s Lyme pledge collides with vaccine history as Pfizer pushes a new jab
RFK Jr., as HHS secretary, pledges stronger action on Lyme disease with better diagnostics and treatment, but his anti-vaccine stance complicates Pfizer/Valneva’s plan to file a Lyme vaccine—the first in more than two decades. The prior Lyme vaccine Lymerix faced safety questions and weak uptake, illustrating the challenges Pfizer now faces, even as Lyme incidence rises with climate-driven tick expansion and researchers pursue vaccines and other preventive tools.













